[1]Bataller R, Brenner DA.Liver fibrosis[J].J Clin Invest, 2005, 115 (2) :209-218.
|
[2]Poynard T, Bedossa P, Opolon P.Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups[J].Lancet, 1997, 349 (9055) :825-832.
|
[3]Boccato S, Pistis R, Noventa F, et al.Fibrosis progression in initially mild chronic hepatitis C[J].J Viral Hepat, 2006, 13 (5) :297-302.
|
[4]Friedman SL.Hepatic stellate cells[J].Prog Liver Dis, 1996, 14:101-130.
|
[5]Friedman SL, Roll FJ, Boyles J, et al.Hepatic lipocytes:the principal collagen-producing cells of normal rat liver[J].Proc Natl Acad Sci U S A, 1985, 82 (24) :8681-8685.
|
[6]Friedman SL.Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury[J].J Biol Chem, 2000, 275 (4) :2247-2250.
|
[7]Friedman SL.Hepatic stellate cells:protean, multifunctional, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.
|
[8]谢渭芬.肝纤维化治疗策略探讨[J].中华消化杂志, 2004, 24 (10) :577-578.
|
[9]Zhong W, Shen WF, Ning BF, et al.Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated siRNA attenuates hepatic fibrosis in rats[J].Hepatology, 2009, 50 (5) :1524-1536.
|
[10]Hu PF, Chen H, Zhong W, et al.Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats[J].J Hepatol, 2009, 51 (1) :102-113.
|
[11]Chen SW, Chen YX, Zhang XR, et al.Targeted Inhibition of platelet-derived growth factor receptorβsubunit in hepatic stellate cells ameliorates hepatic fibrosis in rats[J].Gene Therapy, 2008, 15 (21) :1424-1435.
|
[12]Passino MA, Adams RA, Sikorski SL, et al.Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR[J].Science, 2007, 315 (5820) :1853-1856.
|
[13]Benten D, Kumaran V, Joseph B, et al.Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat[J].Hepatology, 2005, 42 (5) :1072-1081.
|
[14]Kalinichenko VV, Bhattacharyya D, Zhou Y, et al.Foxf1+/-mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury[J].Hepatology, 2003, 37 (1) :107-117.
|
[15]Lorenzini S, Bird TG, Boulter L, et al.Characterisation of a ste-reotypical cellularand extracellular adult liver progenitor cell niche in rodents and diseased human liver[J].Gut, 2010, 59 (5) :645-654.
|
[16]Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, et al.Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes[J].Nat Biotechnol, 2006, 24 (11) :1412-1419.
|
[17] Deng X, Chen YX, Zhang X, et al.Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells[J].J Cell Physiol, 2008, 217 (1) :138-144.
|
[18]Pintilie DG, Shupe TD, Oh SH, et al.Hepatic stellate cells'involvement in progenitor-mediated liver regeneration[J].Lab Invest, 2010, 90 (8) :1199-1208.
|
[19]Kordes C, Sawitza I, Muller-Marbach A, et al.CD133+hepatic stellate cells are progenitor cells[J].Biochem Biophys Res Commun, 2007, 352 (2) :410-417.
|
[20]Yang L, Jung Y, Omenetti A, et al.Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers[J].Stem Cells, 2008, 26 (8) :2104-2113.:
|
[21]Odom DT, Zizlsperger N, Gordon DB, et al.Control of¨pancreas and liver gene expression by HNF transcription factors[J].Science, 2004, 303 (5662) :1378-1381.
|
[22]Parviz F, Matullo C, Garrison WD, et al.Hepatocyte nuclear factor 4αcontrols the development of a hepatic epithelium and liver morphogenesis[J].Nat Genet, 2003, 34 (3) :292-296.
|
[23]Li J, Ning G, Duncan SA.Mammalian hepatocyte differentiation requires the transcription factor HNF-4a[J].Genes Dev, 2000, 14 (4) :464-474.
|
[24]Hayhurst GP, Lee, Lambert G, et al.Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis[J].Mol Cell Biol, 2001, 21 (4) :1393-1403.
|
[25]Yin C, Lin Y, Zhang X, et al.Differentiation Therapy of Hepatocellular Carcinoma in Mice with Recombinant Adenovirus Carrying Hepatocyte Nuclear Factor-4αGene[J].Hepatology, 2008, 48 (5) :1528-1539.
|
[26]Yue HY, Yin C, Hou JL, et al.Hepatocyte nuclear factor 4αattenuates hepatic fibrosis in rats[J].Gut, 2010, 59 (2) :236-246.
|
[27]Ning BF, Ding J, Yin C, et al.Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma[J].Cancer Res, 2010, 70 (19) :7640-7651.
|
[28]Odom DT, Zizlsperger N, Gordon DB, et al.Control of pancreas and liver gene expression by HNF transcription factors[J].Science, 2004, 303 (5662) :1378-1381.
|
[1] | Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004 |
[2] | Zhao WenShan, Xie Wen. Clinical assessment of the reversal of liver cirrhosis: “Point of return”[J]. Journal of Clinical Hepatology, 2019, 35(4): 724-727. doi: 10.3969/j.issn.1001-5256.2019.04.005 |
[3] | Chen YongPeng, Liang XieEr. Radiological evaluation of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 720-723. doi: 10.3969/j.issn.1001-5256.2019.04.004 |
[4] | Liu TianHui. Serological assessment of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 714-719. doi: 10.3969/j.issn.1001-5256.2019.04.003 |
[5] | Tang ChengWei. Work-up for diagnosis and treatment of liver cirrhosis: convention and development[J]. Journal of Clinical Hepatology, 2016, 32(2): 201-202. doi: 10.3969/j.issn.1001-5256.2016.02.001 |
[6] | Han Tao. Acute-on-chronic liver failure due to bacterial infection in liver cirrhosis: causes and management[J]. Journal of Clinical Hepatology, 2015, 31(9): 1415-1417. doi: 10.3969/j.issn.1001-5256.2015.09.012 |
[7] | Zhang JingWen, Shi YongQuan, Han Ying. Progress in treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 465-468. doi: 10.3969/j.issn.1001-5256.2015.03.037 |
[8] | Xie WeiFen, Ceng Xin. Controversial problems in management of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2014, 30(7): 601-603. doi: 10.3969/j.issn.1001-5256.2014.07.006 |
[9] | Lu LunGen, Li ZhengHong. Diagnosis and assessment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 577-579. doi: 10.3969/j.issn.1001-5256.2014.07.001 |
[10] | Wu JianJin, Yao DingKang. Recent advances in understanding the relations between liver cirrhosis and sleep disorders[J]. Journal of Clinical Hepatology, 2013, 29(5): 397-400. |
[11] | Lu LunGen, Li ZhengHong. Recent research on liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(5): 321-323. |
[12] | Wei SiChen, Zheng GuoQi. Role of adipokine in the pathogenesis of cirrhosis of the liver[J]. Journal of Clinical Hepatology, 2012, 28(1): 78-81. |
[13] | Chen Jing, Liu XiaoYan, Hu JinHua, Duan XueZhang, He WeiPing, Wang HuiFen, Xin ShaoJie. Clinical analysis of 24 cases of congenital hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1041-1043. |
[14] | Cao YuNing, Li SenLin. Research in the progress of non-invasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(2): 214-217. |
[15] | Qiu Ling, Hu YuLin. Recent status and prospect of ascites treatment in cirrhosis patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 663-665. |
[16] | Wang CaiSheng. Progress of diagnosis in liver fibrosis[J]. Journal of Clinical Hepatology, 2010, 26(6): 666-668. |
[18] | Li XiaoFeng, Yang XiaoMing, Zhu JianMin, Wang JiXian. The relation between cirrhosis and GERD[J]. Journal of Clinical Hepatology, 2000, 16(4): 243-244. |
[19] | Shang Jia, Wang XiuQi, Jin Xiu, Li YuKui, Li XiuLing. The Targets Hyperfibrinolysis Influence the Prognosis in Cirrhosis Patients[J]. Journal of Clinical Hepatology, 2000, 16(1): 35-36. |